Rossari Biotech Business Update
Rossari Biotech's subsidiary completed the ₹10.50 Crore sale of its Mumbai office premises. The transaction involves non-related parties and was conducted at arm's length.
- Value
- ₹10.50 Cr
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
2,639 announcements with these filters
Rossari Biotech's subsidiary completed the ₹10.50 Crore sale of its Mumbai office premises. The transaction involves non-related parties and was conducted at arm's length.
Maruti Suzuki will increase vehicle prices by up to Rs. 30,000 from June 2026. The move offsets sustained input cost pressures and inflationary environment.
Aurum PropTech sold Buildings Q5 and Q6 for ₹112 Crore. The proceeds retire all existing debt, leaving the company debt-free to fund AI-driven growth.
RHI Magnesita India approved selling industrial land and machinery at its closed Bhilai plant. This divestment follows the facility's operations discontinuation on May 31, 2024.
Strides Pharma's Bangalore facility completed a US-FDA inspection with five Form 483 observations. The company plans to respond within the stipulated timeline to ensure compliance.
Infinium Pharmachem resumed manufacturing operations following a revocation order from the Gujarat Pollution Control Board. The Sojitra facility recommenced regular production activities on May 20, 2026.
Karur Vysya Bank revised its Marginal Cost of Funds Based Lending Rates (MCLR) effective May 22, 2026. Most tenors saw rate reductions, impacting lending yields.
Apollo Micro Systems announced Director Mr. Addepalli Krishna Sai Kumar's interview on ET Now. The interaction will focus on publicly available company information.
Anthem Biosciences Limited disclosed its certified Key Performance Indicators for the financial year ended March 31, 2026. The metrics provide detailed historical operational visibility for investors.
PTC India re-initiates the monetization process for its investment in subsidiary PTC India Financial Services. The board will review opportunities subject to necessary regulatory approvals.
Sumedha Fiscal Services Ltd is selling its Hyderabad property for ₹0.35 Crore. The transaction expects completion by May 31, 2026, improving liquidity through asset monetisation.
SPARC's partner Ocuvex received a US FDA Complete Response Letter for the PDP-716 drug application. The FDA cited manufacturing inspection findings but raised no other issues.
Black Rose Industries received permanent revocation of closure directions for its Jhagadia plant from the GPCB. This allows the facility to resume full operational activities.
Akiko Global Services reported April 2026 turnover of ₹21.02 Crore, achieving 249% year-on-year growth. This estimate demonstrates significant operational expansion compared to previous performance.
EPACK Durable Limited received Entitlement Certificates under the RIPS-2024 scheme for its Bhiwadi facility. Approved incentives include a 10-year turnover-linked incentive and electricity duty exemptions.
Shelter Pharma reports continuous positive customer feedback for its healthcare products across various platforms. This trend strengthens brand credibility and supports long-term growth prospects.
C2C Advanced Systems released its FY 2025-26 business update highlighting expansion in defense and industrial sectors. Key achievements include Indian Navy vendor inclusion and international growth.
Panorama Studios secured Pan-India theatrical distribution rights for the film Dhamaal 4 from Super Cassettes Industries. This strategic agreement strengthens the company's film distribution portfolio.
Bodhtree Consulting announced its GenBI platform has reached advanced beta testing in Australia. Successful UAT feedback will refine the AI-powered tool before its broader commercial rollout.
South Indian Bank revised its MCLR across multiple tenors effective May 20, 2026. The one-year rate is set at 9.45%, influencing future lending yields.
ICRA Limited announced that its subsidiary, ICRA Analytics Limited, recommended a ₹53.7 Crore dividend. This reflects strong financial performance from the company's wholly-owned material subsidiary.
Aditya Birla Capital Limited submitted its Asset Liability Management (ALM) disclosures for April 2026. The filing includes structural liquidity and interest rate sensitivity returns per SEBI guidelines.
Sunshield Chemicals Ltd notified physical security holders to furnish mandatory KYC details to its RTA. The update ensures regulatory compliance for dividend and interest payments.
Piramal Pharma received an Establishment Inspection Report from the US FDA for its Telangana facility. The inspection is successfully closed, ensuring regulatory compliance and operational continuity.
Hindustan Oil Exploration began reselling B-80 crude oil cargo to a third-party buyer. The company continues constructive engagement with HPCL to resolve storage matters amicably.
Hi-Green Carbon resumes operations at its Kukadsar subsidiary plant from May 18, 2026. Restoration is complete following regulatory revocation of the prior closure order.
Allcargo Terminals reported April 2026 volumes of 59,200 TEUs, a 7% year-on-year increase. This monthly update reflects steady operational growth for the terminal operator.
Emcure Pharmaceuticals concluded a US FDA inspection at its Sanand facility with seven procedural observations. The company will address these within the stipulated timeframe.
Sai Life Sciences disclosed certified Key Performance Indicators for fiscal years 2022-2026. The metrics provide detailed visibility into revenue growth, margins, and operational efficiency.
Indian Overseas Bank reduced its Base Rate by 10 bps to 9.70% effective May 15, 2026. The revision follows a periodic review of its rate workings.